← Back to Analyst Consensus 
OPCH Buy
Option Care Health, Inc.
Current Price —
Implied Upside —
Analysts 19
30-Day Momentum
▲ 0 upgrades / ▼ 6 downgrades / 0 reiterations from 6 firms
Next Earnings
Nov 4, 2026 (8 days)
Rating Timeline
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Oct 9, 2026 | UBS | downgrade | Buy → Neutral | — | 54% |
| Oct 7, 2026 | William Blair | downgrade | Outperform → Market Perform | — | 48% |
| Oct 7, 2026 | JP Morgan | downgrade | Overweight → Neutral | — | 55% |
| Oct 7, 2026 | Citizens | downgrade | Market Outperform → Market Perform | — | 47% |
| Oct 7, 2026 | Jefferies | downgrade | Buy → Hold | — | 52% |
| Oct 7, 2026 | Barrington Research | downgrade | Outperform → Market Perform | — | 55% |
| Jul 30, 2026 | Deutsche Bank | downgrade | Buy → Hold | — | 57% |
| Jul 17, 2026 | Stephens & Co. | downgrade | Overweight → Equal-Weight | — | 54% |
| Jun 8, 2026 | Goldman Sachs | initiate | Neutral → Neutral | — | 54% |
| May 6, 2026 | Morgan Stanley | maintain | Overweight → Overweight | — | 54% |
| May 4, 2026 | JP Morgan | maintain | Overweight → Overweight | — | 55% |
| May 1, 2026 | Barrington Research | maintain | Outperform → Outperform | — | 55% |
| May 1, 2026 | UBS | maintain | Buy → Buy | — | 54% |
| May 1, 2026 | TD Cowen | maintain | Hold → Hold | — | 54% |
| Jan 16, 2026 | Barrington Research | maintain | Outperform → Outperform | $42 | 55% |
| Jan 13, 2026 | Morgan Stanley | maintain | Overweight → Overweight | $38 | 54% |
| Jan 13, 2026 | Citizens | reiterate | Market Outperform → Market Outperform | $38 | 47% |
| Dec 11, 2025 | Stephens & Co. | initiate | — → Overweight | $40 | 54% |
| Dec 9, 2025 | B of A Securities | maintain | Buy → Buy | $35 | 53% |
| Dec 9, 2025 | Deutsche Bank | maintain | Buy → Buy | $36 | 57% |
| Nov 3, 2025 | TD Cowen | maintain | Hold → Hold | $27 | 54% |
| Oct 31, 2025 | Citizens | maintain | Market Outperform → Market Outperform | $36 | 47% |
| Oct 31, 2025 | Barrington Research | maintain | Outperform → Outperform | $38 | 55% |
| Oct 17, 2025 | Morgan Stanley | initiate | — → Overweight | $35 | 54% |
| Oct 2, 2025 | TD Cowen | initiate | — → Hold | $30 | 54% |
| Sep 23, 2025 | Barrington Research | maintain | Outperform → Outperform | $38 | 55% |
| Jul 31, 2025 | JMP Securities | maintain | Market Outperform → Market Outperform | $38 | 53% |
| Jul 10, 2025 | Barrington Research | maintain | Outperform → Outperform | $38 | 55% |
| Jun 18, 2025 | JMP Securities | reiterate | Market Outperform → Market Outperform | $36 | 53% |
| Apr 30, 2025 | Barrington Research | maintain | Outperform → Outperform | $38 | 55% |
| Apr 30, 2025 | UBS | upgrade | Neutral → Buy | $40 | 54% |
| Apr 22, 2025 | JMP Securities | reiterate | Market Outperform → Market Outperform | $36 | 53% |
| Apr 21, 2025 | Barrington Research | maintain | Outperform → Outperform | $38 | 55% |
| Mar 6, 2025 | JP Morgan | maintain | Overweight → Overweight | $41 | 55% |
| Feb 27, 2025 | Barrington Research | maintain | Outperform → Outperform | $38 | 55% |
| Jan 24, 2025 | JP Morgan | maintain | Overweight → Overweight | $40 | 55% |
| Jan 23, 2025 | Jefferies | upgrade | Hold → Buy | $35 | 52% |
| Jan 14, 2025 | Barrington Research | maintain | Outperform → Outperform | $33 | 55% |
| Jan 10, 2025 | JMP Securities | reiterate | Market Outperform → Market Outperform | $30 | 53% |
| Dec 5, 2024 | UBS | initiate | — → Neutral | $26 | 54% |
| Nov 5, 2024 | Goldman Sachs | downgrade | Buy → Neutral | $27 | 54% |
| Nov 1, 2024 | Truist Securities | maintain | Buy → Buy | $34 | 54% |
| Oct 31, 2024 | Barrington Research | maintain | Outperform → Outperform | $32 | 55% |
| Oct 31, 2024 | Jefferies | downgrade | Buy → Hold | $26 | 52% |
| Oct 23, 2024 | Barrington Research | maintain | Outperform → Outperform | $40 | 55% |
| Sep 30, 2024 | JMP Securities | maintain | Market Outperform → Market Outperform | $37 | 53% |
| Aug 1, 2024 | Barrington Research | maintain | Outperform → Outperform | $40 | 55% |
| Jul 25, 2024 | Barrington Research | maintain | Outperform → Outperform | $38 | 55% |
| Jul 16, 2024 | JMP Securities | initiate | — → Market Outperform | $36 | 53% |
| Apr 24, 2024 | Barrington Research | maintain | Outperform → Outperform | $38 | 55% |
Price Target Trend
Apr 21, 2026 Oct 26, 2026
EPS Estimates
+1q —
0q —
+1y —
0y —
Cross-Platform Signals
No cross-platform signals in the last 90 days